|Security||BNKL / Bionik Laboratories Corp. (09074A109)|
|Chairman and CEO||Bloch Peter D.|
|Industry||Orthopedic, Prosthetic, and Surgical Appliances and Supplies|
|Common Shares Outstanding||350,383,160 shares (as of 2018-06-30)|
Institutional Stock Ownership and Shareholders
Bionik Laboratories Corp. (OTC:BNKL) has 0 institutional investors and shareholders that have
filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
Largest shareholders include
Bionik Laboratories Corp. (OTC:BNKL) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
as of ET